1. bookVolumen 70 (2020): Edición 1 (March 2020)
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés
Acceso abierto

Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets

Publicado en línea: 01 Nov 2019
Volumen & Edición: Volumen 70 (2020) - Edición 1 (March 2020)
Páginas: 49 - 61
Aceptado: 04 Apr 2019
Detalles de la revista
License
Formato
Revista
eISSN
1846-9558
Primera edición
28 Feb 2007
Calendario de la edición
4 veces al año
Idiomas
Inglés

1. X. Huang, E. Dorhout Mees, P. Vos, S. Hamza and B. Braam, Everything we always wanted to know about furosemide but were afraid to ask, Am. J. Physiol.-Ren. Physiol. 310 (2016) 958–971; https://doi.org/10.1152/ajprenal.00476.201510.1152/ajprenal.00476.2015Search in Google Scholar

2. S. Kumar and M. A. Kumar, Preformulation study of furosemide, Der Pharmacia Lettre8 (2016) 214–222.Search in Google Scholar

3. G. Pacifici, Clinical pharmacology of furosemide in neonates: A review, Pharmaceuticals6 (2013) 1094–1129; https://doi.org/0.3390/ph609109410.3390/ph6091094Search in Google Scholar

4. S. W. Oh and S. Y. Han, Loop diuretics in clinical practice, Electrolytes Blood Press. 13 (2015) 17–21; https://doi.org/10.5049/EBP.2015.13.1.1710.5049/EBP.2015.13.1.17Search in Google Scholar

5. S. Strauch, E. Jantratid, J. B. Dressman, H. E. Junginger, S. Kopp, K. K. Midha, V. P. Shah, S. Stavchansky and D. M. Barends. Biowaiver monographs for immediate release solid oral dosage forms: mefloquine hydrochloride, J. Pharm. Sci,99 (2010) 2544–2556; https://doi.org/10.1002/jps.2224910.1002/jps.22249Search in Google Scholar

6. M. Vlachou and G. Papaïoannou, Preparation and characterization of the inclusion complex of furosemide with hydroxypropyl-b-cyclodextrin, J. Biomater. Appl. 17 (2003) 197–206; https://doi.org/10.1177/088532820301700355710.1177/0885328203017003557Search in Google Scholar

7. A. Deshmukh, P. Nakhat and P. Yeole, Formulation and in-vitro evaluation of self microemulsifying drug delivery system (SMEDDS) of furosemide, Der Pharmacia Lettre2 (2010) 94–106.Search in Google Scholar

8. S. Sambaraj, D. Ammula and V. Nagabandi, Furosemide loaded silica-lipid hybrid microparticles: Formulation development, in vitro and ex vivo evaluation, Adv. Pharm. Bull.5 (2015) 403–409.Search in Google Scholar

9. N. J. Clear, A. Milton, M. Humphrey, B. T. Henry, M. Wulff, D. J. Nichols, R. J. Anziano and I. Wilding, Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon, Eur. J. Pharm. Sci.13 (2001) 375–384.10.1016/S0928-0987(01)00134-8Search in Google Scholar

10. L. Å. Brodin, Τ. Jogestrand, F. Larsen, G. Walldius and B. Tedner, Effects of furosemide and slow-release furosemide on thoracic fluid volumes, Clin. Cardiol. 9 (1986) 561–564; https://doi.org/10.1002/clc.496009110710.1002/clc.4960091107Search in Google Scholar

11. Μ. Efentakis, A. Koutlis and M. Vlachou, Development and evaluation of oral multiple-unit and single-unit hydrophilic controlled-release systems, AAPS Pharm. Sci. Tech.1 (2000) 62–70; https://doi.org/10.1208/pt01043410.1208/pt010434Search in Google Scholar

12. D. Jain, S. Verma, S. B. Shukla, A. K. Jain, P. Jain, P. Yadav, Formulation and evaluation of gastro-retentive tablets of Furosemide (Evaluation based on drug release kinetics and factorial designs), J. Chem. Pharm. Res. 2 (2010) 935–978.Search in Google Scholar

13. T. Terao, K. Matsuda and H. Shouji, Improvement in site-specifc intestinal absorption of furosemide by Eudragit L100-55, JPP53 (2001) 433–440.10.1211/0022357011775721Search in Google Scholar

14. J. M. Aceves, R. Cruz and E. Hernandez, Preparation and characterization of furosemide-eudragit controlled release systems, Int. J. Pharm. 195 (2000) 45–53; https://doi.org/10.1016/S0378-5173(99)00303-810.1016/S0378-5173(99)00303-8Search in Google Scholar

15. M. Vlachou, A. Siamidi, S. Konstantinidou and Y. Dotsikas, Optimization of controlled release matrix formulation of melatonin via experimental design, JPDDR5 (2016) 1–5; https://doi.org/10.4172/2325-9604.100015910.4172/2325-9604.1000159Search in Google Scholar

16. M. Vlachou, A. Siamidi and M. Efentakis, Investigation of a novel “tablets in capsule” theophyl-line formulation system for modified release, Pharm. Pharmacol. Int. J.5 (2017) 51–56; https://doi.org/10.15406/ppij.2017.05.0011510.15406/ppij.2017.05.00115Search in Google Scholar

17. M. Vlachou, A. Siamidi, E. Diamantidi, A. Iliopoulou, I. Papanastasiou, V. Ioannidou, V. Kourbeli, A.-S. Foscolos, A. Vocat, S. T. Colec, V. Karalis, T. Kellici and T. Mavromoustakos, In vitro controlled release from solid pharmaceutical formulations of two new adamantane aminoethers with antitubercular activity (I) Drug Res. 67 (2017) 447–450; https://doi.org/10.1055/s-0042-12149110.1055/s-0042-12149128561241Search in Google Scholar

18. M. Vlachou, A. Siamidi, D. Spaneas, D. Lentzos, P. Ladia, K. Anastasiou, I. Papanastasiou, A-S. Foscolos, M-O. Georgiadis, V. Karalis, T. Kellici and T. Mavromoustakos, In vitro controlled release of two new tuberculocidal adamantane aminoethers from solid pharmaceutical formulations (II) Drug Res.67 (2017) 653–660; https://doi.org/10.1055/s-0043-11401210.1055/s-0043-11401228724167Search in Google Scholar

19. M. Vlachou, M. Papamichael, A. Siamidi, I. Fragouli, P. A. Afroudakis, R. Kompogennitaki and Y. Dotsikas, Comparative in vitro controlled release studies on the chronobiotic hormone melatonin from cyclodextrins-containing matrices and cyclodextrin: Melatonin complexes, Int. J. Mol. Sci.18 (2017) 1641; https://doi.org/10.3390/ijms1808164110.3390/ijms18081641557803128788064Search in Google Scholar

20. M. Vlachou, K.Tragou, A. Siamidi, S. Kikionis, A. L. Chatzianagnostou, A. Mitsopoulos, E. Ioannou, V. Roussis and A. Tsotinis, Modified in vitro release of the chronobiotic hormone melatonin from matrix tablets based on the marine sulfated polysaccharide ulvan, J. Drug Deliv. Sci. Technol. 44 (2018) 41–48; https://doi.org/10.1016/j.jddst.2017.11.01910.1016/j.jddst.2017.11.019Search in Google Scholar

21. M. Vlachou, S. Kikionis, A. Siamidi, K. Tragou, S. Kapoti, E. Ioannou, V. Roussis and A. Tsotinis. Fabrication and characterization of electrospun nanofibers for the modified release of the chronobiotic hormone melatonin, Curr. Drug Deliv.16 (2019) 79–85; https://doi.org/10.2174/156720181566618091409570110.2174/1567201815666180914095701634015330215335Search in Google Scholar

22. S. Bose and R. H. Bogner, Solventless pharmaceutical coating processes: A review, Pharm. Dev. Techn.12 (2007) 115–131; https://doi.org/10.1080/1083745070121247910.1080/1083745070121247917510883Search in Google Scholar

23. M. Efentakis and M. Vlachou, Evaluation of high molecular weight poly(oxyethylene) (polyox) polymer: Studies of flow properties and release rates of furosemide and captopril from controlled-release hard gelatin capsules, Pharm. Dev. Technol. 5 (2000) 339–346; https://doi.org/10.1081/PDT-10010054910.1081/PDT-100100549Search in Google Scholar

24. O. Mansour, G. Ismail, M. Isbera and M. Almouhammad, Assessment of physicochemical properties of furosemide (40 mg) tablets marketed in Syria, JCPS9 (2016) 2879–2881.Search in Google Scholar

25. https://www.jchps.com/issues/Volume%209_Issue%204/jchps%209(4)%20223%200570616%202879-2881.pdfSearch in Google Scholar

26. K.A. Khan, The concept of dissolution efficiency, J. Pharm. Pharmacol. 27 (1975) 48–49; https://doi.org/10.1111/j.2042-7158.1975.tb09378.x10.1111/j.2042-7158.1975.tb09378.x235616Search in Google Scholar

27. W. R. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharmaceut. 15 (1983) 25–35; https://doi.org/10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9Search in Google Scholar

28. N. A. Peppas and J. J. Sahlin, A simple equation for the description of solute release coupling of diffusion and relaxation, Int. J. Pharmaceut. 57 (1989) 169–172; https://doi.org/10.1016/0378-5173(89)90306-210.1016/0378-5173(89)90306-2Search in Google Scholar

29. G. Singhvi and M. Singh, Review: in-vitro drug release characterization models, Int. J. Pharm. Sci. Res.2 (2011) 77–84.Search in Google Scholar

30. S. Ummadi, B. Shravani, N. G. Raghavendra Rao, S. Reddy, B. Sanjeev, Overview on controlled release dosage form, Int. J. Pharm. Sci.3 (2013) 258–269; http://ijps.aizeonpublishers.net/content/2013/4/ijps258-269.pdfSearch in Google Scholar

31. S. Bose and R. H. Bogner, Solventless pharmaceutical coating processes: A review, Pharm. Dev. Technol.12 (2007) 115–131 https://doi.org/10.1080/1083745070121247910.1080/10837450701212479Search in Google Scholar

32. X. Gong, C.C. Sun, A new tablet brittleness index, Eur. J. Pharm. Biopharm.93 (2015) 260–266; https://doi.org/10.1016/j.ejpb.2015.04.00710.1016/j.ejpb.2015.04.007Search in Google Scholar

33. M. Han, Q. Yu, X. Liu, F. Hu and H. Yuan, Preparation and characterization of a novel aqueous dispersion for enteric coating of pantoprazole sodium pellets, Acta Pharm.68 (2018) 441–455; https://doi.org/https://doi.org/10.2478/acph-2018-003510.2478/acph-2018-0035Search in Google Scholar

34. J. Akbuga, Preparation and evaluation of controlled release furosemide microspheres by spherical crystallization, Int. J. Pharm. 53 (1999) 99–105; https://doi.org/10.1016/0378-5173(89)90233-010.1016/0378-5173(89)90233-0Search in Google Scholar

35. B. N.Tukaram, I. V. Rajagopalan and P. S. Ikumar Shartchandra, The effects of lactose, microcrystalline cellulose and dicalcium phosphate on swelling and erosion of compressed hpmc matrix tablets: texture analyzer, Iranian J. Pharm. Res.9 (2010) 349–358.Search in Google Scholar

36. V. Iannuccelli, G. Coppi, E. Leo, F. Fontana and M. T. Bernabei, PVP solid dispersions for the controlled release of furosemide from a floating multiple-unit system, Drug Dev. Ind. Pharm.26 (2000) 595–603.10.1081/DDC-100101274Search in Google Scholar

37. A. Cismesia, G. R. Nicholls and N. C. Polfer, Amine vs. carboxylic acid protonation in ortho-, meta-, and para aminobenzoic acid: An IRMPD spectroscopy study, J. Mol. Spectrosc. 332 (2017) 79–85; https://doi.org/10.1016/j.jms.2016.10.02010.1016/j.jms.2016.10.020Search in Google Scholar

38. A. Apicella, B. Cappello, M. A. Del Nobile, M. I. La Rotonda, G. Mensitieria and L. Nicolais, Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release, Biomaterials14 (1993) 83–90; https://doi.org/10.1016/0142-9612(93)90215-N10.1016/0142-9612(93)90215-NSearch in Google Scholar

Artículos recomendados de Trend MD

Planifique su conferencia remota con Sciendo